Clinicians managing critically ill patients face the daily challenge of polypharmacy. Consequently, implementing effective drug-drug interaction screening becomes essential to prevent adverse events. A recent study in Japan evaluated whether traditional package inserts perform adequately compared to global databases like Lexi-Interact. This research specifically focused on injectable medications in intensive care unit (ICU) settings.

Performance of Package Insert-Based Screening

The retrospective cohort study analyzed 345 adult ICU admissions at a tertiary hospital. Researchers evaluated interactions at three specific timepoints during the patient stay. Interestingly, package insert-based screening demonstrated a high negative predictive value (NPV) of 0.98. Furthermore, it showed a sensitivity of 0.80 and a specificity of 0.91. These results suggest that package inserts are highly reliable for ruling out potential drug-drug interactions. However, the positive predictive value (PPV) remained relatively low at 0.51.

Optimizing Drug-Drug Interaction Screening in Critical Care

Agreement between the Japanese package inserts and Lexi-Interact was moderate, with a weighted kappa of 0.57. Most interactions that package inserts missed belonged to Lexi-Interact Category C. Notably, only one missed interaction was Category D, and none were Category X. Therefore, package inserts serve as a practical initial screening tool in busy clinical environments. Nevertheless, relying solely on them might lead to overlooking certain moderate interactions. Consequently, clinicians may benefit from using international databases to supplement their safety checks.

Clinical Implications for ICU Safety

Maintaining medication safety in the ICU requires high vigilance. While package inserts are accessible and accurate for primary screening, they do not replace clinical judgment. Moreover, discrepancies in severity classification highlight the need for standardized electronic decision support tools. Integrating both local guidelines and international databases could significantly enhance patient outcomes and minimize medication errors.

Frequently Asked Questions

How accurate are package inserts for drug-drug interaction screening in the ICU?

Package inserts are highly accurate for identifying and ruling out major interactions, showing high sensitivity and negative predictive value in recent clinical studies.

Should clinicians use Lexi-Interact instead of package inserts?

While Lexi-Interact provides more comprehensive data on moderate interactions, package inserts are effective for initial screening. Ideally, clinicians should use both to ensure maximum patient safety.

Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional relationship. Refer to the latest local and national guidelines for clinical practice.

References

Kato T et al. Diagnostic performance of package insert-based screening for potential drug-drug interactions in ICU patients receiving injectable medications: a retrospective diagnostic accuracy study using Lexi-Interact as the comparator in Japan. J Intensive Care. 2026 Jun 16. doi: 10.1186/s40560-026-00890-7. PMID: 42304184.

Smithburger PL, Kane-Gill SL, Benedict NJ, Falcione BA, Seybert AL. Characterization of drug-drug interactions in critically ill patients. Crit Care Res Pract. 2012;2012:273473.

Zheng WY, Richardson LC, Li L, et al. Profiling the performance of two drug-drug interaction alerts in an electronic health record system. Appl Clin Inform. 2011;2(2):187-200.